Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-19
2010-12-14
Desai, Rita J (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S207000, C514S343000
Reexamination Certificate
active
07851632
ABSTRACT:
This invention provides compounds of formula I:wherein a, b, c, m, p, s, t, W, Ar1, X1, R1, R2, R3, R4, R6, and R7are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
REFERENCES:
patent: 6617325 (2003-09-01), Lehmann-Lintz et al.
patent: 6635764 (2003-10-01), Mammen et al.
patent: 6656694 (2003-12-01), Mammen
patent: 6693202 (2004-02-01), Aggen et al.
patent: 7141671 (2006-11-01), Mammen et al.
patent: 7265133 (2007-09-01), Mammen et al.
patent: 7345175 (2008-03-01), Mammen et al.
patent: 7632847 (2009-12-01), Mu et al.
patent: 7687519 (2010-03-01), Mu et al.
patent: 2003/0018019 (2003-01-01), Meade et al.
patent: 2004/0209860 (2004-10-01), Mammen et al.
patent: 2004/0209915 (2004-10-01), Mammen et al.
patent: 2005/0113417 (2005-05-01), Mammen et al.
patent: 2005/0203083 (2005-09-01), Mammen et al.
patent: 2005/0203131 (2005-09-01), Mammen et al.
patent: 2005/0203132 (2005-09-01), Mammen et al.
patent: 2005/0203133 (2005-09-01), Mammen et al.
patent: 2005/0203134 (2005-09-01), Mammen et al.
patent: 2005/0203137 (2005-09-01), Mammen et al.
patent: 2005/0203139 (2005-09-01), Mammen et al.
patent: 2006/0205777 (2006-09-01), Mu et al.
patent: 2006/0205778 (2006-09-01), Mu et al.
patent: 2006/0205779 (2006-09-01), Mu et al.
patent: 2006/0205946 (2006-09-01), Mu et al.
patent: 2009/0048299 (2009-02-01), Mammen et al.
patent: 2010/0063096 (2010-03-01), Mu et al.
patent: 0 747 355 (1996-12-01), None
patent: WO 95/06635 (1995-03-01), None
patent: WO 99/64043 (1999-12-01), None
patent: WO 01/42212 (2001-06-01), None
patent: WO 02/051841 (2002-07-01), None
patent: WO 2004/012684 (2004-02-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Broadley et al., “Muscarinic Receptor Agonists and Antagonists”, Molecules, 6, pp. 142-193 (2001).
Eglen et al., “Muscarinic Receptor Subtypes:Pharmacology and Therapeutic Potential”, DN&P, 10(8), pp. 462-469 (1997).
Naito et al., “Selective Muscarinic Antagonist. II.1)Synthesis and Antimuscarinic Properties of Biphenylylcarbamate Derivatives”, Chem. Pharm. Bull. , vol. 46, No. 8, pp. 1286-1294 (1998).
Zlotos et al., “Muscarinic receptor agonists and antagonists”, Exp. Opin. Ther. Patents, 9(8), pp. 1029-1053 (1999).
Husfeld Craig
Ji Yu-Hua
Li Li
Mammen Mathai
Mu YongQi
Desai Rita J
Eberle Shelley
Hagenah Jeffrey A.
Theravance Inc.
LandOfFree
Biphenyl compounds useful as muscarinic receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenyl compounds useful as muscarinic receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl compounds useful as muscarinic receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151988